Semaglutide was found to increase the risk of deep vein thrombosis by 266% and diarrhea by 166%
For the first time, Williams is speaking openly about her own experience, and explains that despite disciplined training and healthy eating, her body simply didnt respond the way it once did after having children
Who This Cluster Is For People seeking long-term metabolic stability , not temporary appetite suppression Individuals using GLP-1 medications who want durable outcomes Anyone struggling with cravings, stress eating, or appetite swings Those with gut issues, inflammation, fatigue, or metabolic slowdown Readers looking for science-driven, microbiome-based insight How to Navigate This Cluster Start with Blog 1 understand GLP-1 biology Continue with Blogs 24 learn how diet, microbes, stress, and rhythms interact Finish with Blog 5 integrate everything into a complete metabolic blueprint Revisit as needed each article stands alone Why GLP-1 Outcomes Improve When the Microbiome Is Repaired GLP-1 medications suppress appetite, but they do not correct: dysbiosis impaired SCFA production circadian disruption gut-barrier inflammation stress-driven appetite loops When microbiome function is restored, GLP-1 sensitivity improves , SCFA pathways activate, cravings stabilize, and metabolic flexibility returns
Moreover, CUD has been associated with a higher risk for psychotic disorders [7, 8], self-harm, and suicidal behaviors [9,10,11]
Key Differences Between Vitamin B6 and B12 The differences between these key nutrients help you make informed dietary choices
.webp)
